# SARS‐CoV‐2 Anti‐S an Anti‐N IgG Seropositivity in Children and Young People (1–24 Years) According to HIV Status in Lomé (Togo) in 2022

## TL;DR

This study found no increased risk of SARS-CoV-2 infection in children and young people with HIV in Togo.

## Contribution

The study compares SARS-CoV-2 seropositivity in HIV-positive and HIV-negative children and young people.

## Key findings

- Anti-S and anti-N IgG seropositivity rates were similar between HIV-positive and HIV-negative participants.
- Children and young people with HIV do not appear to be more susceptible to SARS-CoV-2.

## Abstract

We aimed to estimate SARS‐CoV‐2 seropositivity among children and young people in Lomé, Togo, according to HIV status. A multicenter comparative cross‐sectional study was conducted, and 636 participants were included (41.8% living with HIV). Anti‐S (88.7% vs. 89.1%) and anti‐N (41.6% vs. 39.5%) IgG seropositivity were comparable in both groups. These data suggest no increased COVID‐19 susceptibility in children and young people with HIV.